Private Equity
Voatz, a voting and citizen engagement platform, has raised $7 million in Series A funding. Medici Ventures and Techstars led the round with participation from Urban Innovation Fund and Oakhouse Partners.
1 min read · 06 June 2019
Silicon Valley-based AllyO, a provider of AI recruiting solutions, has $45 million in Series B funding, according to a blog post on its site. The investors were Sapphire Ventures, Scale Venture Partners, Gradient Ventures, Randstad Innovation Fund, Bain Capital Ventures and Cervin Ventures.
1 min read · 06 June 2019
Palo Alto, California-based Yellowbrick Data, an analytics provider, has secured $81 million in Series C funding. DFJ Growth led the round.
1 min read · 06 June 2019
Legacy, a male fertility startup, has secured $1.5 million in funding. Bain Capital Ventures led the round.
1 min read · 06 June 2019
Intelex Technologies, a Toronto-based provider of software solutions for environment, health, safety and quality (EHSQ) programs, has agreed to be acquired by Industrial Scientific for about $770 million (US$570 million). The sellers are JMI Equity and HarbourVest Partners. JMI, a U.S. growth equity firm, four years ago led a $160 million financing of Intelex. The deal is expected to close by Q3 2019, after which Intelex will operate as a stand-alone unit of Industrial Scientific. Based in Pittsburgh, Pennsylvania, Industrial Scientific is a gas detection management and safety solutions affiliate of Fortive Corp (NYSE: FTV). Industrial Scientific and Intelex said the acquisition is the largest in the history of EHSQ pureplay vendors.
4 min read · 06 June 2019
TVM Capital Life Science and Caisse de dépôt et placement du Québec (CDPQ) are the 2019 recipients of the Canadian Venture Capital & Private Equity Association's (CVCA) Deal of the Year awards. TVM Capital won in the venture capital category for the 2018 sale of AurKa Pharma, a Montréal-based developer of a cancer treatment for solid tumors, to Eli Lilly. The US$575 million deal generated an IRR of 348 percent and 9.3 x multiple of invested capital. CDPQ won in the private equity category for the 2018 sale of Camso, a Magog, Québec-based maker of off-the-road tires and rubber tracks to Michelin. The transaction was valued at US$1.45 billion.
5 min read · 05 June 2019
TVM Capital Life Science and Caisse de dépôt et placement du Québec (CDPQ) are the 2019 recipients of the Canadian Venture Capital & Private Equity Association's (CVCA) Deal of the Year awards. TVM Capital won in the venture capital category for the 2018 sale of AurKa Pharma, a Montréal-based developer of a cancer treatment for solid tumors, to Eli Lilly. The US$575 million deal generated an IRR of 348 percent and 9.3 x multiple of invested capital. CDPQ won in the private equity category for the 2018 sale of Camso, a Magog, Québec-based maker of off-the-road tires and rubber tracks to Michelin. The transaction was valued at US$1.45 billion.
5 min read · 05 June 2019
The federal government’s Venture Capital Catalyst Initiative (VCCI) has committed $50 million to ArcTern Ventures, Cycle Capital Management and Renewal Funds, all Canadian venture capital firms active in the clean technology sector. Montréal-based Cycle and Vancouver-based Renewal will receive $20 million apiece, the Globe and Mail reported, while Toronto-based ArcTern will get $10 million. ArcTern initially closed its second fund last year, raising $60 million, while Cycle initially closed its fourth fund in February, raising $109 million. VCCI, a $400 million program to shore up venture capital supply in Canada, in 2018 secured an additional $50 million from Ottawa earmarked for clean technology.
3 min read · 05 June 2019
Jazz Venture Partners has raised a $287 million venture-capital fund focused on companies improving human performance, according to a filing with the SEC.
1 min read · 05 June 2019
Jazz Venture Partners has raised a $287 million venture-capital fund focused on companies improving human performance, according to a filing with the SEC.
1 min read · 05 June 2019
